Literature DB >> 7763254

Point mutation of the somatostatin receptor 2 gene in the human small cell lung cancer cell line COR-L103.

C Y Zhang1, Y Yokogoshi, K Yoshimoto, Y Fujinaka, K Matsumoto, S Saito.   

Abstract

The effect of somatostatin (SS) on adrenocorticotrophic hormone (ACTH) secretion from COR-L103 cells derived from a human small cell lung carcinoma was examined. SS at 1 microM had no effect on ACTH secretion from the cells on either short-term or long-term incubation. Studies by the reverse transcription-polymerase chain reaction (RT-PCR) showed that mRNA transcripts of the somatostatin receptor (SSTR) 2, SSTR3 and SSTR4 genes were present in COR-L103 cells. Extra bands were obtained by PCR-single strand conformation polymorphism (SSCP) analysis of the SSTR2 gene Sequence analysis of the SSTR2 gene demonstrated one point mutation in codon 188 of TGG for tryptophan to TGA for a stop codon causing loss of 182 C-terminal amino acid residues of SSTR2. The nucleotide sequences of the SSTR3 and SSTR4 genes in COR-L103 cells were normal. Binding studies using 125I-Tyr11-SS-14 showed specific affinity binding sites on COR-L103 cells and mouse pituitary tumor AtT-20 cells. Octreotide acetate suppressed the binding of 125I-Tyr11-SS-14 to these two cell lines, but the Kd of COR-L103 cells (160 nM) was 60-fold higher than that of AtT-20 cells (2.6 nM). Affinity cross-linking studies using 125I-Tyr11-SS-14 gave three bands of 72 KDa, 55 KDa and 32 KDa from AtT-20 cells, but only two bands of 55KDa and 32kDa from COR-L103 cells. These findings suggest that SSTR2 is not expressed in the plasma membranes of COR-L103 cells due to a point mutation, but that this may have no influence on the effect of SS on ACTH secretion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7763254     DOI: 10.1006/bbrc.1995.1730

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Somatostatin receptor (SSTR) expression and function in normal and leukaemic T-cells. Evidence for selective effects on adhesion to extracellular matrix components via SSTR2 and/or 3.

Authors:  T Talme; J Ivanoff; M Hägglund; R J Van Neerven; A Ivanoff; K G Sundqvist
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

2.  SSTR5 P335L monoclonal antibody differentiates pancreatic neuroendocrine neuroplasms with different SSTR5 genotypes.

Authors:  Guisheng Zhou; Marie-Claude Gingras; Shi-He Liu; Robbi Sanchez; Dean Edwards; David Dawson; Kurt Christensen; Giovanni Paganelli; Richard Gibbs; William Fisher; Francis C Brunicardi
Journal:  Surgery       Date:  2011-12       Impact factor: 3.982

Review 3.  Somatostatin receptors and their interest in diagnostic pathology.

Authors:  Marco Volante; Francesca Bozzalla-Cassione; Mauro Papotti
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

4.  Treatment with octreotide to suppress corticotropin secretion by a carcinoid tumour.

Authors:  Eugenia B Tirovola; James S Malpas
Journal:  J R Soc Med       Date:  2005-11       Impact factor: 18.000

5.  Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2(SSTR2) gene at 17q24.

Authors:  F Abel; K Ejeskär; P Kogner; T Martinsson
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.